Shanghai Allist Pharmaceuticals Co., Ltd. engages in the innovative pharmaceutical company in the field of cancer treatment. Its products include furmonertinib and pralsetinib Capsules. The company was founded by Du Jin Hao on March 22, 2004 and is headquartered in Shanghai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company